Karen Wasilewski-Masker

Summary

Affiliation: Children's Healthcare of Atlanta
Country: USA

Publications

  1. doi request reprint Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
    Louis Rapkin
    Division of Pediatric Hematology Oncology, AFLAC Cancer Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 59:854-8. 2012
  2. pmc Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study
    K Wasilewski-Masker
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, 5455 Meridian Mark Road, Suite 400, Atlanta, GA, 30342, USA
    J Cancer Surviv 8:437-47. 2014
  3. doi request reprint Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature
    Karen Wasilewski-Masker
    Division of Pediatric Hematology Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Pediatrics 121:e705-13. 2008
  4. pmc Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study
    Karen Wasilewski-Masker
    Aflac Cancer Center and Blood Disorders Service, Children s Healthcare of Atlanta at Scottish Rite, 5455 Meridian Mark Rd, Ste 400, Atlanta, GA 30342, USA
    J Natl Cancer Inst 101:1709-20. 2009
  5. doi request reprint Severity of health conditions identified in a pediatric cancer survivor program
    Karen Wasilewski-Masker
    The Aflac Cancer Center and Blood Disorders Service at Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30342, USA
    Pediatr Blood Cancer 54:976-82. 2010
  6. doi request reprint Pediatric quality of life in long-term survivors of childhood cancer treated with anthracyclines
    A Blythe Ryerson
    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
    Pediatr Blood Cancer 63:2205-2211. 2016
  7. doi request reprint Assessment of family psychosocial functioning in survivors of pediatric cancer using the PAT2.0
    Jordan Gilleland
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, GA, USA
    Psychooncology 22:2133-9. 2013
  8. doi request reprint Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy
    Swati V Elchuri
    Division of Endocrinology and Metabolism, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia Electronic address
    J Pediatr Adolesc Gynecol 29:393-9. 2016
  9. doi request reprint Perceptions of body mass index (BMI) in pediatric cancer survivors and their providers
    Swati V Elchuri
    Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia
    Pediatr Blood Cancer 61:1445-50. 2014
  10. doi request reprint Analysis of Risk Factors for Abnormal Pulmonary Function in Pediatric Cancer Survivors
    Elizabeth Record
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, Georgia
    Pediatr Blood Cancer 63:1264-71. 2016

Collaborators

Detail Information

Publications23

  1. doi request reprint Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
    Louis Rapkin
    Division of Pediatric Hematology Oncology, AFLAC Cancer Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 59:854-8. 2012
    ..Patients with relapsed pediatric sarcomas have a poor outcome and are in need of novel effective therapies...
  2. pmc Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study
    K Wasilewski-Masker
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, 5455 Meridian Mark Road, Suite 400, Atlanta, GA, 30342, USA
    J Cancer Surviv 8:437-47. 2014
    ..The purpose of this study was to assess the prevalence of male infertility and treatment-related risk factors in childhood cancer survivors...
  3. doi request reprint Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature
    Karen Wasilewski-Masker
    Division of Pediatric Hematology Oncology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
    Pediatrics 121:e705-13. 2008
    ....
  4. pmc Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study
    Karen Wasilewski-Masker
    Aflac Cancer Center and Blood Disorders Service, Children s Healthcare of Atlanta at Scottish Rite, 5455 Meridian Mark Rd, Ste 400, Atlanta, GA 30342, USA
    J Natl Cancer Inst 101:1709-20. 2009
    ..We sought to estimate late recurrence rates for the most common pediatric cancers and to determine risk factors for late recurrence...
  5. doi request reprint Severity of health conditions identified in a pediatric cancer survivor program
    Karen Wasilewski-Masker
    The Aflac Cancer Center and Blood Disorders Service at Children s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30342, USA
    Pediatr Blood Cancer 54:976-82. 2010
    ..0 (CTCAE) was designed for reporting acute and late effects of cancer treatment. To date, no study of pediatric-aged cancer survivors has graded health conditions using CTCAE, for patients in active follow-up in a cancer survivor program...
  6. doi request reprint Pediatric quality of life in long-term survivors of childhood cancer treated with anthracyclines
    A Blythe Ryerson
    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
    Pediatr Blood Cancer 63:2205-2211. 2016
    ..Linear regression was used to evaluate the association between PedsQL scores and anthracycline cardiotoxicity risk status and to assess whether self-reported physical activity modified the association...
  7. doi request reprint Assessment of family psychosocial functioning in survivors of pediatric cancer using the PAT2.0
    Jordan Gilleland
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, GA, USA
    Psychooncology 22:2133-9. 2013
    ..This study aimed to examine clinical validity and utility of a screening measure for familial psychosocial risk, the Psychosocial Assessment Tool 2.0 (PAT2.0), among pediatric cancer survivors participating in long-term survivorship care...
  8. doi request reprint Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy
    Swati V Elchuri
    Division of Endocrinology and Metabolism, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia Electronic address
    J Pediatr Adolesc Gynecol 29:393-9. 2016
    ..To obtain anti-Müllerian hormone (AMH) levels in female childhood cancer survivors and determine the association of therapeutic exposures with diminished ovarian reserve (DOR)...
  9. doi request reprint Perceptions of body mass index (BMI) in pediatric cancer survivors and their providers
    Swati V Elchuri
    Division of Endocrinology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia
    Pediatr Blood Cancer 61:1445-50. 2014
    ..Perceptions of BMI status in cancer survivors have been understudied. This study determines the accuracy of parent/survivor and provider reporting of BMI status in a cancer survivor program...
  10. doi request reprint Analysis of Risk Factors for Abnormal Pulmonary Function in Pediatric Cancer Survivors
    Elizabeth Record
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, Georgia
    Pediatr Blood Cancer 63:1264-71. 2016
    ..The aim of this analysis was to determine the prevalence of pulmonary function abnormalities in a pediatric survivor cohort...
  11. doi request reprint Infertility Education: Experiences and Preferences of Childhood Cancer Survivors
    Brooke O Cherven
    Children s Healthcare of Atlanta, Atlanta, GA, USA
    J Pediatr Oncol Nurs 33:257-64. 2016
    ..End of therapy and survivorship may be times this message should be repeated and adapted for the survivor's needs and developmental stage: conversations about the impact of cancer treatment on future fertility should be ongoing. ..
  12. pmc Yield of Urinalysis Screening in Pediatric Cancer Survivors
    Matthew D Ramirez
    Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia
    Pediatr Blood Cancer 63:893-900. 2016
    ..0 of the COG Long-Term Follow-Up Guidelines and identify possible risk factors for abnormal screening in a survivor population...
  13. doi request reprint Perceptions of Infertility Risks Among Female Pediatric Cancer Survivors Following Gonadotoxic Therapy
    Jordan Gilleland Marchak
    Departments of Pediatrics, Hematology Oncology Pediatrics, Endocrinology, Emory University School of Medicine Aflac Cancer Center, Children s Healthcare of Atlanta, Atlanta, GA
    J Pediatr Hematol Oncol 37:368-72. 2015
    ..Overall, these findings reinforce the necessity of developmentally appropriate education about reproductive health risks and fertility preservation options across the continuum of pediatric oncology care from diagnosis to survivorship. ..
  14. doi request reprint Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography
    A Blythe Ryerson
    Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
    Pediatr Blood Cancer 62:502-8. 2015
    ..We examined childhood cancer survivors treated with anthracyclines during exercise using various echocardiography techniques to investigate if these tools can better detect subclinical cardiac dysfunction...
  15. pmc Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program
    Ann C Mertens
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Emory University, Atlanta, Georgia
    Cancer 121:1108-17. 2015
    ..Long-term survivors of pediatric cancer are at risk of life-threatening late effects of their cancer. Previous studies have shown excesses in long-term mortality within high-risk groups defined by demographic and treatment characteristics...
  16. doi request reprint Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program
    Briana C Patterson
    Emory University School of Medicine, Department of Pediatrics, M S, Emory Children s Center, 2015 Uppergate Drive, Suite 232 NE, Atlanta, Georgia 30322, USA
    J Clin Endocrinol Metab 97:810-8. 2012
    ..Many pediatric cancer survivors have endocrine conditions. Surveillance for late effects is recommended by national guidelines. Endocrine surveillance is recommended after alkylating agents, steroids, methotrexate, and radiation...
  17. doi request reprint Adrenal function testing in pediatric cancer survivors
    Briana C Patterson
    Division of Endocrinology, Department of Pediatrics, Emory University, Atlanta, Georgia, USA
    Pediatr Blood Cancer 53:1302-7. 2009
    ..Central adrenal insufficiency is observed after cranial radiation therapy for cancer. Screening at risk patients is recommended, but the best screening strategy is unknown...
  18. pmc Erectile Dysfunction in Male Survivors of Childhood Cancer-A Report From the Childhood Cancer Survivor Study
    Chad W M Ritenour
    Department of Urology, Emory University School of Medicine, Atlanta, GA, USA Electronic address
    J Sex Med 13:945-54. 2016
    ..Late effects resulting from cancer and cancer therapy are being characterized, but little information exists on sexual health for men who have survived childhood cancer...
  19. pmc Factors associated with recruiting adult survivors of childhood cancer into clinic-based research
    Ann C Mertens
    Department of Pediatrics, Emory University, Children s Healthcare of Atlanta, Atlanta, Georgia
    Pediatr Blood Cancer 61:1846-51. 2014
    ..Little is known about the potential success of recruiting adult survivors of childhood cancer into research projects that would require a risk-based health evaluation within a clinical setting...
  20. doi request reprint Knowledge and risk perception of late effects among childhood cancer survivors and parents before and after visiting a childhood cancer survivor clinic
    Brooke Cherven
    AFLAC Cancer and Blood Disorders Center, Children s Healthcare of Atlanta, Atlanta, GA, USA
    J Pediatr Oncol Nurs 31:339-49. 2014
    ..This suggests that perceived likelihood of developing a late effect is an important factor in the individuals' ability to learn about their risk and should be addressed before initiation of education. ..
  21. pmc The Effect of Transition Clinics on Knowledge of Diagnosis and Perception of Risk in Young Adult Survivors of Childhood Cancer
    Rohit G Ganju
    Departments of Medicine Radiation Oncology Pediatrics, Emory University School of Medicine Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, GA
    J Pediatr Hematol Oncol 38:197-201. 2016
    ..The current study evaluated the impact of previous engagement in survivor care on patient knowledge and awareness of health risks as young adults...
  22. doi request reprint Intracavitary cisplatin therapy for pediatric malignancies
    Howard M Katzenstein
    AFLAC Cancer Center and Blood Disorders Services, Division of Pediatric Hematology Oncology, Emory University School of Medicine and Children s Healthcare of Atlanta, Atlanta, Georgia, USA
    Pediatr Blood Cancer 55:452-6. 2010
    ..The aim of the study was to determine the toxicity and efficacy of locally instilled intracavitary cisplatin in patients with recurrent tumors in closed body cavities...
  23. doi request reprint Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study
    Nina S Kadan-Lottick
    Section of Pediatric Hematology Oncology, Yale University School of Medicine, New Haven, CT 06520, USA
    J Clin Oncol 26:3038-45. 2008
    ..Osteonecrosis (ON) is a potentially serious complication of therapy in survivors of childhood cancer. Our goals were to describe the incidence of ON and identify patient and treatment characteristics associated with elevated risk...